Taking a fresh look at counterfeiting in pharma and medical devices: from root cause to current solution

Available:

On Demand

Price:

Complimentary

Details

Speakers

Watch Now

Overview

As pharma companies have improved patients’ access to safe medicines, the value of pharma brands has grown. It is attracting not just investors, but also counterfeiters. The WHO estimates up to 8% of medical devices on the market are fakes, as are up to 30% of medicines. The rise of new technologies and more complex value chains have made fighting counterfeit medical products more challenging. Yet it is a priority for patient safety and brand reputation. Clariant, the global leader in speciality chemicals, and SICPA, a global provider of security solutions, have joined forces to bring protection closer to the medicine. In the process, they are helping healthcare companies re-think security for pharma products, including medical devices and pharma packaging. If you are in charge of your company’s brands or supply chain, come join us in this webinar. Among other topics, we will: • discuss the sources of counterfeiting • explore the tools and technologies on the market and what they were designed to do • examine the current landscape in terms of technologies

Learning Objectives:

  • Which tools are relevant in the market and how are they designed to achieve anti-counterfeiting?
  • Counterfeiting of medical devices and pharma packaging: myth or reality?
  • Is anti-counterfeiting embedded into your risk management?
  • The fight against fakes: where do we stand?